HIF-1α and HIF-2α correlate with migration and invasion in gastric cancer

Cancer Biology and Therapy

Volumn 10, Issue 4, 2010, Pages 376-382

  Wang, Yanxia ^a   Li, Zhichao ^a   Zhang, Hongbo ^b   Jin, Haifeng ^b   Sun, Li ^b   Dong, Haiying ^a   Xu, Min ^a   Zhao, Pengtao ^a   Zhang, Bo ^a   Wang, Jin ^a   Pan, Yanglin ^b   Liu, Lili ^c  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; HIF 1 ; HIF 2 ; Hypoxia; Invasion; Migration

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE;

ADULT; ARTICLE; CANCER INVASION; CANCER TISSUE; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH CANCER; WESTERN BLOTTING;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; CELL ADHESION; CELL HYPOXIA; CELL LINE, TUMOR; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; IMMUNOHISTOCHEMISTRY; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LYMPHATIC METASTASIS; MAP KINASE SIGNALING SYSTEM; NEOPLASM INVASIVENESS; POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; STOMACH NEOPLASMS;

EID: 77957146784     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.10.4.12441     Document Type: Article

References (40)

1. Höckel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic and molecular aspects. J Natl Cancer Inst 2001; 93:266-76.
2. Harris AL. Hypoxia-a key regulatory factor in tumour growth. Nature Rev Cancer 2002; 2:38-47.
3. Wu H, Liang X, Fang Y, Qin X, Zhang Y, Liu J. Resveratrol inhibits hypoxia-induced metastasis potential enhancement by restricting hypoxia-induced factor-1a expression in colon carcinoma cells. Biomed Pharmacother 2008; 62:613-21.
4. Semenza GL. HIF-1 and human disease: one highly involved factor. Genes Dev 2000; 14:1983-91.
5. Löfstedt T, Fredlund E, Holmquist-Mengelbier L, Pietras A, Ovenberger M, Poellinger L, et al. Hypoxia inducible factor-2alpha in cancer. Cell Cycle 2007; 6:919-26.
6. Rasheed S, Harris AL, Tekkis PP, Turley H, Silver A, McDonald PJ, et al. Hypoxia-inducible factor-1alpha and -2alpha are expressed in most rectal cancers but only hypoxia-inducible factor-1alpha is associated with prognosis. Br J Cancer 2009; 100:1666-73.
7. Lee JY, Choi JY, Lee KM, Park SK, Han SH, Noh DY, et al. Rare variant of hypoxia-Inducible factor-1alpha (HIF-1α) and breast cancer risk in Korean women. Clin Chim Acta 2008; 389:167-70.
8. Beasley NJ, Leek R, Alam M, Turley H, Cox GJ, Gatter K, et al. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res 2002; 62:2493-7.
9. Imamura T, Kikuchi H, Herraiz MT, Park DY, Mizukami Y, Mino-Kenduson M, et al. HIF-1alpha and HIF-2alpha have divergent roles in colon cancer. Int J Cancer 2009; 124:763-71.
10. Song IS, Wang AG, Yoon SY, Kim JM, Kim JH, Lee DS, et al. Regulation of glucose metabolism-related genes and VEGF by HIF-1alpha and HIF-1beta, but not HIF-2alpha, in gastric cancer. Exp Mol Med 2009; 41:51-8.
11. Holmquist-Mengelbier L, Fredlund E, Lofstedt T, Noguera R, Navarro S, Nilsson H, et al. Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell 2006; 10:413-23.
12. Raval RR, Lau KW, Tran MG, Sowter HM, Mandriota SJ, Li JL, et al. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol 2005; 25:5675-86.
13. Li Y, Qiu X, Zhang S, Zhang Q, Wang E. Hypoxia induced CCR7 expression via HIF-1α and HIF-2α correlates with migration and invasion in lung cancer cells. Cancer Biol Ther 2009; 8:322-30.
14. Takahashi R, Tanaka S, Hiyama T, Ito M, Kitadai Y, Sumii M, et al. Hypoxia-inducible factor-1alpha expression and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncol Rep 2003; 10:797-802.
15. Chen WT, Huang CJ, Wu MT, Yang SF, Su YC, Chai CY. Hypoxia-inducible factor-1alpha is associated with risk of aggressive behavior and tumor angiogenesis in gastrointestinal stromal tumor. Jpn J Clin Oncol 2005; 35:207-13.
16. Huang SP, Wu MS, Shun CT, Wang HP, Hsieh CY, Kuo ML, et al. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma. J Biomed Sci 2005; 12:229-41.
17. Sumiyoshi Y, Kakeji Y, Egashira A, Mizokami K, Orita H, Maehara Y. Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer. Clin Cancer Res 2006; 12:5112-7. (Pubitemid 44453338)
18. Stoeltzing O, McCarty MF, Wey JS, Fan F, Liu W, Belcheva A, et al. Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis and vessel maturation. J Natl Cancer Inst 2004; 96:946-56.
19. Urano N, Fujiwara Y, Doki Y, Tsujie M, Yamamoto H, Miyata H, et al. Overexpression of hypoxia-inducible factor-1alpha in gastric adenocarcinoma. Gastric Cancer 2006; 9:44-9.
20. Rohwer N, Lobitz S, Daskalow K, Jöns T, Vieth M, Schlag PM, et al. HIF-1alpha determines the metastatic potential of gastric cancer cells. Br J Cancer 2009; 100:772-81.
21. Li L, Ning X, Li Sun, Zhang H, Shi Y, Guo C, et al. Hypoxia-inducible factor-1á contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci 2008; 99:121-8.
22. Griffiths EA, Pritchard SA, McGrath SM, Valentine HR, Price PM, Welch IM, et al. Hypoxia-associated markers in gastric carcinogenesis and HIF-2alpha in gastric and gastro-oesophageal cancer prognosis. Br J Cancer 2008; 98:965-73.
23. Ito M, Tanaka S, Kim S, Kuwai T, Matsutani N, Kamada T, et al. The specific expression of hypoxia inducible factor-1alpha in human gastric mucosa induced by nonsteroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2003; 18:90-8.
24. Liu L, Sun L, Zhang H, Ning X, Sun S, Guo C, et al. Hypoxia-Mediated Up-Regulation of MGr1-Ag/37LRP in gastric cancers occurs via Hypoxia-inducible-Factor 1-Dependent Mechanism and contributes to Drug Resistance. Int J Cancer 2009; 124:1707-15.
25. Chavez JC, Baranova O, Lin J, Pichiule P. The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes. J Neurosci 2006; 26:9471-81. (Pubitemid 44396860)
26. Thamilselvan V, Basson MD. Pressure activates colon cancer cell adhesion by inside-out focal adhesion complex and actin cytoskeletal signaling. Gastroenterology 2004; 126:8-18.
27. Wang F, Reierstad S, Fishman DA. Matrilysin overexpression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation. Cancer Lett 2006; 236:292-301.
28. Liu L, Ning X, Han S, Zhang H, Sun L, Shi Y, et al. Hypoxia induced HIF-1 accumulation and VEGF expression in gastric epithelial mucosa cell: involvement of ERK1/2 and PI3K/Akt. Mol Biol 2008; 42:459-69.
29. Yao H, Wang H, Zhang Z, Jiang BH, Luo J, Shi X. Sulforaphane inhibited expression of hypoxia-inducible factor-1alpha in human tongue squamous cancer cells and prostate cancer cells. Int J Cancer 2008; 123:1255-61.
30. Ratcliffe PJ. HIF-1 and HIF-2: working alone or together in hypoxia? J Clin Invest 2007; 117:862-5.
31. Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ, et al. The expression and distribution of the hypoxia-inducible factors HIF-1a and HIF-2a in normal human tissues, cancers and tumor-associated macrophages. American Journal of Pathology 2000; 157:411-21. (Pubitemid 30626905)
32. Khasigov PZ, Podobed OV, Gracheva TS, Salbiev KD, Grachev SV, Berezov TT. Role of matrix metalloproteinases and their inhibitors in tumor invasion and metastasis. Biochemistry 2003; 68:711-77.
33. Hynes RO. Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both? Cell 2003; 113:821-23.
34. Hundt C, Gauczynski S, Leucht C, Riley ML, Weiss S. Intra- and interspecies interactions between prion proteins and effects of mutations and polymorphisms. Biol Chem 2003; 384:791-803.
35. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004; 10:789-99. (Pubitemid 39070849)
36. Comerford KM, Cummins EP, Taylor CT. c-Jun NH2-Terminal kinase activation contributes to Hypoxia-Inducible Factor1á-dependent P-glycoprotein expression in hypoxia. Cancer Res 2004; 64:9057-61.
37. Blaschke F, Stawowy P, Goetze S, Hintz O, Michael G, Kintscher U, et al. Hypoxia activates beta(1)-integrin via ERK 1/2 and p38 MAP kinase in human vascular smooth muscle cells. Biochem Biophys Res Commun 2002; 296:890-6.
38. Lester RD, Jo M, Campana WM, Gonias SL. Erythropoietin promotes MCF-7 breast cancer cell migration by an ERK/mitogen-activated protein kinase-dependent pathway and is primarily responsible for the increase in migration observed in hypoxia. J Biol Chem 2005; 25:39273-7.
39. Löfstedt T, Fredlund E, Holmquist-Mengelbier L, Pietras A, Ovenberger M, Poellinger L, et al. Hypoxia-inducible factor-2alpha in cancer. Cell Cycle 2007; 6:919-26.
40. Cao Z, Fang J, Xia C, Shi X, Jiang BH. Trans-3,4,5′- Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells. Clin Cancer Res 2004; 10:5253-63.